dapi has been researched along with Myocardial Infarction in 7 studies
DAPI: RN given refers to parent cpd.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wendel, JS | 1 |
| Ye, L | 1 |
| Zhang, P | 1 |
| Tranquillo, RT | 1 |
| Zhang, JJ | 1 |
| Lu, WN | 1 |
| Lü, SH | 1 |
| Wang, HB | 1 |
| Li, DX | 1 |
| Duan, CM | 1 |
| Liu, ZQ | 1 |
| Hao, T | 1 |
| He, WJ | 1 |
| Xu, B | 1 |
| Fu, Q | 1 |
| Song, YC | 1 |
| Xie, XH | 1 |
| Wang, CY | 1 |
| Lu, M | 1 |
| Zhao, S | 1 |
| Liu, Q | 1 |
| Jiang, S | 1 |
| Song, P | 1 |
| Qian, H | 1 |
| Zhang, Y | 1 |
| Ling, J | 1 |
| Yan, C | 1 |
| Cheng, H | 1 |
| Ma, N | 1 |
| Zhao, H | 1 |
| Liu, Y | 1 |
| Tang, YL | 1 |
| Zimmermann, WH | 1 |
| Melnychenko, I | 1 |
| Wasmeier, G | 1 |
| Didié, M | 1 |
| Naito, H | 1 |
| Nixdorff, U | 1 |
| Hess, A | 1 |
| Budinsky, L | 1 |
| Brune, K | 1 |
| Michaelis, B | 1 |
| Dhein, S | 1 |
| Schwoerer, A | 1 |
| Ehmke, H | 1 |
| Eschenhagen, T | 1 |
| Miyahara, Y | 1 |
| Nagaya, N | 1 |
| Kataoka, M | 1 |
| Yanagawa, B | 1 |
| Tanaka, K | 1 |
| Hao, H | 1 |
| Ishino, K | 1 |
| Ishida, H | 1 |
| Shimizu, T | 1 |
| Kangawa, K | 1 |
| Sano, S | 1 |
| Okano, T | 1 |
| Kitamura, S | 1 |
| Mori, H | 1 |
| Müller-Ehmsen, J | 1 |
| Krausgrill, B | 1 |
| Burst, V | 1 |
| Schenk, K | 1 |
| Neisen, UC | 1 |
| Fries, JW | 1 |
| Fleischmann, BK | 1 |
| Hescheler, J | 1 |
| Schwinger, RH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell (hMSC) Infusion in Patients With Non-Cystic Fibrosis Bronchiectasis[NCT02625246] | Phase 1 | 6 participants (Actual) | Interventional | 2016-02-04 | Completed | ||
| A Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Mild Asthma[NCT03137199] | Phase 1 | 3 participants (Actual) | Interventional | 2017-06-22 | Terminated (stopped due to First cohort completed. Per sponsor decision.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dapi and Myocardial Infarction
| Article | Year |
|---|---|
Autologous mesenchymal stem cells for post-ischemic myocardial repair.
Topics: Animals; Bone Marrow Cells; Cells, Cultured; Disease Models, Animal; Fluorescent Antibody Technique, | 2005 |
6 other studies available for dapi and Myocardial Infarction
| Article | Year |
|---|---|
Functional consequences of a tissue-engineered myocardial patch for cardiac repair in a rat infarct model.
Topics: Animals; Disease Models, Animal; Electrocardiography; Extracellular Matrix; Implants, Experimental; | 2014 |
Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel.
Topics: Acridine Orange; Animals; Cell Differentiation; Cell Line; Cell Survival; Chitosan; Embryonic Stem C | 2009 |
Transplantation with autologous mesenchymal stem cells after acute myocardial infarction evaluated by magnetic resonance imaging: an experimental study.
Topics: Animals; Cell Differentiation; Dextrans; Immunohistochemistry; Indoles; Magnetic Resonance Imaging; | 2012 |
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.
Topics: Animals; Animals, Newborn; Calcium; Dose-Response Relationship, Drug; Echocardiography; Electric Sti | 2006 |
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.
Topics: Animals; Animals, Genetically Modified; Cell Differentiation; Cells, Cultured; Disease Models, Anima | 2006 |
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.
Topics: Animals; Animals, Genetically Modified; Cell Differentiation; Cells, Cultured; Disease Models, Anima | 2006 |
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.
Topics: Animals; Animals, Genetically Modified; Cell Differentiation; Cells, Cultured; Disease Models, Anima | 2006 |
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.
Topics: Animals; Animals, Genetically Modified; Cell Differentiation; Cells, Cultured; Disease Models, Anima | 2006 |
Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction.
Topics: Acute Disease; Animals; Bone Marrow Cells; Cell Differentiation; Chronic Disease; Fluorescent Dyes; | 2006 |